Author

Nixon Niyonzima

Primary ORCID profile (0000-0001-7489-6813 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nixon NiyonzimaiD2 papers · Uganda Cancer Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Moses Joloba· 1 shared Mulumba Yusuf· 1 shared Obondo J. Sande· 1 shared Paul Katongole· 1 shared Steven J Reynolds· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Moses Joloba

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2015 and 2019 at the Uganda Cancer Institute

Paul Katongole, Obondo J. Sande, Mulumba Yusuf, Moses Joloba, Steven J Reynolds, Nixon Niyonzima

This study reports clinical characteristics and primary management of prostate cancer patients at the Uganda Cancer Institute between 2015 and 2019, finding most patients presented with advanced disease and received chemotherapy, hormonal therapy, or radiotherapy.

bioRxiv · Jul 9, 2020Cancer Biology